AbC-19 rapid antibody test explained
The AbC-19 rapid antibody test is an immunological test for COVID-19 exposure developed by the UK Rapid Test Consortium and manufactured by Abingdon Health. It uses a lateral flow test to determine whether a person has IgG antibodies to the SARS-CoV-2 virus that causes COVID-19. The test uses a single drop of blood obtained from a finger prick and yields results in 20 minutes. The sensitivity of this test is 98.03% while the specificity is 99.56%.[1] This test is paired with an easy-to-use mobile app which allows a trained professional to generate an antibody test certificate for storing on a person's smartphone.[1] [2]
See also
External links
Notes and References
- Web site: AbC-19 COVID-19 Rapid Antibody Test and Certificate Solution IgG. 2021-08-02. Abingdon Health plc. en-GB.
- Mulchandani . R . Jones . HE . Taylor-Phillips . S . Shute . J . Perry . K . Jamarani . S . Brooks . T . Charlett . A . Hickman . M . Oliver . I . Kaptoge . S . Danesh . J . Di Angelantonio . E . Ades . AE . Wyllie . DH . EDSAB-HOME and COMPARE . Investigators. . Accuracy of UK Rapid Test Consortium (UK-RTC) "AbC-19 Rapid Test" for detection of previous SARS-CoV-2 infection in key workers: test accuracy study. . BMJ (Clinical Research Ed.) . 11 November 2020 . 371 . m4262 . 10.1136/bmj.m4262 . 33177070 . 7656121 .